Stay updated with breaking news from Analysis Results. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Applied Therapeutics, Inc. announced positive interim 12-month results from the ongoing Phase 3 INSPIRE trial, in which the primary endpoints and several key secondary endpoints were achieved. The...
Interim primary endpoint met; Statistically significant correlation of sorbitol with the CMT-FOM clinical outcome composite Sustained, statistically significant reduction in sorbitol in...
PUEBLO, Colo. –– RAILWAY TRACK AND STRUCTURES, OCTOBER 2023 ISSUE –– MxV RAIL
-- Evorpacept is the first CD47 blocker to show activity in a global randomized study in solid tumors -- Interim efficacy results showed the confirmed overall response rate for evorpacept...
ALX Oncology Holdings Inc. announced positive prespecified interim Phase 2 data from its ASPEN-06 clinical trial, a randomized multi-center international study evaluating evorpacept, the Company?s...